Literature DB >> 30914201

PET imaging of 11C-labeled coenzyme Q10: Comparison of biodistribution between [11C]ubiquinol-10 and [11C]ubiquinone-10.

Kyosuke Watanabe1, Satoshi Nozaki2, Miki Goto2, Ken-Ichi Kaneko2, Emi Hayashinaka2, Satsuki Irie2, Akira Nishiyama3, Kazuaki Kasai4, Kenji Fujii3, Yasuhiro Wada2, Kei Mizuno5, Kenji Mizuseki6, Hisashi Doi2, Yasuyoshi Watanabe7.   

Abstract

Coenzyme Q10 (CoQ10) plays a key role not only as an essential electron carrier in the mitochondrial electron transport chain, but also as an antioxidant to protect cells from oxidative stress. CoQ10 supplementation is expected to be effective for a variety of diseases. The predominant forms of CoQ10 are the ubiquinol-10 (reduced form) and ubiquinone-10 (oxidized form). Both forms of CoQ10 supplements are commercially available, however, their kinetic difference is still unclear. In order to conduct in vivo analysis of the kinetics of ubiquinol-10 and ubiquinone-10, we succeeded in synthesizing 11C-labeled ubiquinol-10 ([11C]UQL) and ubiquinone-10 ([11C]UQN), respectively. In the present study, we aimed to investigate the kinetics of [11C]UQL and [11C]UQN, both of which were administered via the tail vein of 8-week-old male Sprague-Dawley rats. Whole-body positron emission tomography (PET) imaging was performed to follow the time course of accumulation in the liver, spleen, brain, and other organs. Then, at the two typical time points at 20 or 90 min after injection, we conducted the biodistribution study. Various organs/tissues and blood were collected, weighed and counted with a gamma counter. Percent injected dose per gram of tissue (%ID/g) was calculated as the indicator of the accumulation of each compound. As the results, at both time points, %ID/g of [11C]UQL in the cerebrum, cerebellum, white adipose tissue, muscle, kidney, and testis were higher (P < 0.05) than that of [11C]UQN: at 90-min time point, %ID/g of [11C]UQL in the brown adipose tissue was higher (P < 0.05) than that of [11C]UQN: on the contrary, %ID/g of [11C]UQL in the spleen was lower (P < 0.05) than that of [11C]UQN at 90 min. In a separate study of the metabolite analysis in the plasma, UQL injected into the tail vein of rats was almost unchanged during the PET scanning time, but UQN was gradually converted to the reduced form UQL. Therefore, the uptake values of UQL into the tissues and organs were rather accurate but those of UQN might be the sum of UQN uptake and partly converted UQL uptake. These studies suggested that the accumulation level of administered CoQ10 differs depending on its redox state, and that CoQ10 redox state could be crucial for optimization of the effective supplementation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biodistribution; Coenzyme Q(10); Metabolism; PET; Ubiquinol; Ubiquinone

Mesh:

Substances:

Year:  2019        PMID: 30914201     DOI: 10.1016/j.bbrc.2019.03.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Ubiquinol-10 Intake Is Effective in Relieving Mild Fatigue in Healthy Individuals.

Authors:  Kei Mizuno; Akihiro T Sasaki; Kyosuke Watanabe; Yasuyoshi Watanabe
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

2.  Assessing Cellular Uptake of Exogenous Coenzyme Q10 into Human Skin Cells by X-ray Fluorescence Imaging.

Authors:  Theresa Staufer; Mirja L Schulze; Oliver Schmutzler; Christian Körnig; Vivienne Welge; Thorsten Burkhardt; Jens-Peter Vietzke; Alexandra Vogelsang; Julia M Weise; Thomas Blatt; Oliver Dabrowski; Gerald Falkenberg; Dennis Brückner; Carlos Sanchez-Cano; Florian Grüner
Journal:  Antioxidants (Basel)       Date:  2022-08-06

3.  Bioavailability of Reduced Coenzyme Q10 (Ubiquinol-10) in Burn Patients.

Authors:  Naohide Kuriyama; Tomoyuki Nakamura; Harumasa Nakazawa; Tyler Wen; Lorenzo Berra; Edward A Bittner; Jeremy Goverman; Masao Kaneki
Journal:  Metabolites       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.